Stay updated on Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial
Sign up to get notified when there's something new on the Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial page.

Latest updates to the Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page shows a 403 Forbidden error, indicating restricted access to the study record.SummaryDifference0.2%

- Check18 days agoChange DetectedThe page now renders a 403 Forbidden error instead of the study record content, effectively blocking access to the study details and linked documents on this page.SummaryDifference18%

- Check39 days agoChange DetectedThe page now shows a newer revision tag (v3.6.6) replacing the previous v3.6.5, indicating a minor site update. The update does not alter the study details, eligibility criteria, or outcome measures.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page shows a new revision label: v3.6.5, replacing v3.6.4. This indicates a minor backend/page template update rather than changes to the study details.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page revision has been updated from v3.6.3 to v3.6.4, indicating a new build of the site. This appears to be a minor maintenance update and does not alter the study details or eligibility information.SummaryDifference0.0%

- Check96 days agoChange DetectedThe site version was updated from v3.6.2 to v3.6.3. This appears to be a backend software update with no visible changes to study content or page functionality.SummaryDifference0.0%

Stay in the know with updates to Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial page.